Welcome to our dedicated page for Carecloud SEC filings (Ticker: CCLDP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding CareCloud’s healthcare-IT disclosures can feel like tackling both clinical jargon and SaaS accounting in one sitting. The CareCloud quarterly earnings report 10-Q filing alone buries key subscription metrics beneath layers of regulatory language, while tracking CareCloud insider trading Form 4 transactions demands constant EDGAR refreshes. If you’ve wondered, “Where can I download the numbers without spending hours?” this page was built for you.
Our AI analyses every document seconds after it posts, turning dense text into insights so concise they read like notes. Think of CareCloud SEC filings explained simply: we surface churn rates, RCM margins, and HIPAA risk updates straight from the source. Need the CareCloud annual report 10-K simplified? It’s here. Curious about an acquisition noted in an 8-K? See CareCloud 8-K material events explained in plain English. Even board vote details from the CareCloud proxy statement executive compensation are summarized alongside the original PDF.
Professionals use these tools for alert-level speed and context. Real-time dashboards flag CareCloud Form 4 insider transactions real-time, and our trend charts deliver CareCloud earnings report filing analysis across quarters. By understanding CareCloud SEC documents with AI, you can spot changes in deferred revenue, compare R&D intensity, or monitor CareCloud executive stock transactions Form 4 before material announcements. Less time parsing, more time acting—every filing, every metric, always current.
CareCloud, Inc. reported that Director Cameron Munter had 7,500 restricted stock units vest and convert into common stock on 08/08/2025 under the companys Amended and Restated Equity Incentive Plan without payment by the reporting person.
After the vesting and conversion, Munter is reported to beneficially own 189,000 shares of common stock and to hold 40,000 restricted stock units (derivative securities) remaining. The Form 4 was signed by Norman Roth as attorney-in-fact for Cameron Munter.
Anne Busquet, a director of CareCloud, Inc. (CCLD), reported that 7,500 restricted stock units vested and converted into common stock on 08/08/2025. The filing states these shares were issued under the Company's Amended and Restated Equity Incentive Plan and were acquired without payment.
The Form 4 shows the transaction recorded with code M (conversion upon vesting) and reports her direct beneficial ownership following the transaction as 281,388 common shares. Table II also reports 40,000 derivative securities beneficially owned following the reported transactions. The form is signed by attorney-in-fact Norman Roth on 08/08/2025.
CareCloud, Inc. (CCLD) director John N Daly converted 7,500 restricted stock units (RSUs) into common stock on 08/08/2025 under the Company’s Amended and Restated Equity Incentive Plan. The shares issued upon vesting were acquired without payment by the reporting person.
Following the reported transaction Mr. Daly beneficially owns 76,750 shares of common stock directly and is shown as beneficial owner of 40,000 derivative securities (restricted stock units). The Form 4 discloses a routine equity compensation vesting and conversion into common shares.
CareCloud director Bill Korn had 7,500 restricted stock units vest and convert into common stock on 08/08/2025 under the company’s Amended and Restated Equity Incentive Plan without payment by the reporting person.
The conversion added 7,500 shares to his direct holdings, bringing his total reported direct beneficial ownership to 197,883 shares, while his reported derivative holdings following the transaction were 40,000 RSU-equivalent securities. The filing records this routine equity compensation event for a director and documents the change in beneficial ownership.
Lawrence S. Sharnak, a director of CareCloud, Inc., had 7,500 restricted stock units vest and convert into 7,500 shares of common stock on 08/08/2025 under the company's Amended and Restated Equity Incentive Plan. The filing states the shares and the underlying units were issued without payment by the reporting person. After the reported transaction the Form 4 shows 114,000 shares of common stock beneficially owned and 40,000 derivative securities (restricted stock units) reported as beneficially owned, both in a direct ownership form.